Malvern, PA - YPrime announces the release of its data-driven electronic clinical outcome assessment (eCOA) technology platform. Designed to capture endpoints from multiple modalities and streamline patient data collection in clinical trials, YPrime's eCOA technology supports sponsors, sites and patients while delivering consumer-friendly applications built on the best standards of user experience principles.
YPrime's eCOA solutions offer data capture in virtually any clinical research setting, with features that promote user convenience, compliance and data integrity:
"YPrime's approach to eCOA is a great example of our collective efforts to uncomplicate patient data collection," said Shawn Blackburn, CEO and co-founder. "This platform, which offers the most advanced features in the marketplace, provides the tools that make clinical endpoint collection quicker, easier and considerably less frustrating. Technology that focuses on the end user's experience, particularly for site and patients will have a landmark effect on the way we conduct clinical trials in the future."
About YPrime
YPrime offers more than a decade of focused work with eclinical systems to expedite and improve the quality of patient management, clinical supplies, drug accountability and clinical data. Cloud-based interactive response technology (IRT) and electronic clinical outcome assessment (eCOA) platforms enable greater speed, precision and integration in clinical trial management. Our data services tools help sponsors bring together fragmented clinical research data into contextual information they can act on. YPrime's technology and service offerings enable sponsors to move faster and more efficiently to their next development milestone.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.